These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Vitiligo: new possibilities in the treatment and its adverse effects]. Petzoldt D Hautarzt; 1973 May; 24(5):221-2. PubMed ID: 4753376 [No Abstract] [Full Text] [Related]
24. Simultaneous determination of aminothiols, ascorbic acid and uric acid in biological samples by capillary electrophoresis with electrochemical detection. Yao X; Wang Y; Chen G Biomed Chromatogr; 2007 May; 21(5):520-6. PubMed ID: 17294501 [TBL] [Abstract][Full Text] [Related]
25. Studies on antioxidants in atherosclerosis. Iwahashi H Nagoya J Med Sci; 1970 Jan; 32(2):327-45. PubMed ID: 5439377 [No Abstract] [Full Text] [Related]
27. Treatment of vitiligo. Lerner AB JAMA; 1969 Feb; 207(5):960. PubMed ID: 5818268 [No Abstract] [Full Text] [Related]
28. [Changes in the content of epinephrine and norepinephrine in the blood of patients with vitiligo]. Durneva SG Vestn Dermatol Venerol; 1973 Oct; 47(10):33-6. PubMed ID: 4782173 [No Abstract] [Full Text] [Related]
29. [Hormonal activity of the adrenal glands and sulfhydryl groups in the gastric mucosa in secretory insufficiency of the stomach]. Kas'ianenko IV; Korobeĭnik FG Vrach Delo; 1967; 9():13-6. PubMed ID: 5621769 [No Abstract] [Full Text] [Related]
30. [Blood serum content of sulfhydryl compounds in patients with chronic glomerulonephritis]. Bazanov IuI Vrach Delo; 1974 Sep; 0(9):86-8. PubMed ID: 4428723 [No Abstract] [Full Text] [Related]
31. "ABO blood groups and vitiligo". Mohan L; Singh G; Kaur P; Pandey SS; Mohan R; Niyogi AK Indian J Dermatol; 1982 Apr; 27(2):60-2. PubMed ID: 7129532 [No Abstract] [Full Text] [Related]
32. Treatment of vitiligo with oral methoxsalen and UVA. Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291 [TBL] [Abstract][Full Text] [Related]
33. Treatment of vitiligo with broadband ultraviolet B and vitamins. Don P; Iuga A; Dacko A; Hardick K Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381 [TBL] [Abstract][Full Text] [Related]
34. [Histochemical changes in the skin of patients with vitiligo during treatment with Psoralen]. Abdullakhodzhaeva MS; Abidov MM Vestn Dermatol Venerol; 1968 Jan; 42(1):24-6. PubMed ID: 5741206 [No Abstract] [Full Text] [Related]
35. Levels of malondialdehyde and antioxidants in the blood of patients with vitiligo of age group 11-20 years. Jain D; Misra R; Kumar A; Jaiswal G Indian J Physiol Pharmacol; 2008; 52(3):297-301. PubMed ID: 19552063 [TBL] [Abstract][Full Text] [Related]
36. Localized vitiligo successfully treated with cream-psoralen + ultraviolet A. Kreuter A; Gambichler T; Avermaete A; Jansen T; Altmeyer P; von Kobyletzki G J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):357-8. PubMed ID: 11730053 [No Abstract] [Full Text] [Related]
37. [In vitro study of emulsions containing methoxsalen]. Kata M; Józsa P; Aigner Z Acta Pharm Hung; 2000 Apr; 70(2):35-40. PubMed ID: 11192738 [TBL] [Abstract][Full Text] [Related]